Company intelligence / Profile preview
WARF Therapeutics
Madison, Wisconsin, United Stateswarf.org ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
WARF Therapeutics advances early-stage drug candidates from academic research at UW–Madison through preclinical validation. Programs focus on demonstrating in vivo proof-of-concept before seeking licensing or partnerships for further clinical development. No clinical results have been published as all programs remain preclinical.
- Therapeutic areas
- OncologyOther
- Modalities
- Small moleculeRadiopharmaceutical
- Industry
- Biotech
02
Drug pipeline
5 assets4 more assets in the full pipeline.
03
Partnerships
University of Wisconsin–Madison researchers/principal investigatorsMorgridge Institute for Research principal investigatorsSHINE TechnologiesSanford Burnham Prebys Medical Discovery Institute
Beyond the preview
Go deeper on WARF Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on WARF Therapeutics.